Skip to search formSkip to main contentSkip to account menu

abciximab

Known as: 7E3, abciximab [Chemical/Ingredient], C7E3 
A Fab fragment of the chimeric monoclonal antibody 7E3 and inhibitor of the glycoprotein (GP) IIb/IIIa receptor, that blocks platelet aggregation… 
National Institutes of Health

Related topics

Related topics

20 relations
5 ML abciximab 2 MG/ML Injection [ReoPro]Angina, UnstableBrain NeoplasmsCerebral Infarction

Broader (4)

AnticoagulantsFab ImmunoglobulinsMonoclonal AntibodiesPlatelet Aggregation Inhibitors

Narrower (2)

ClotinabReoPro

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Visualisation of thrombus formation on prosthetic valve by real-time three-dimensional transoesophageal echocardiography
A 40-year-old woman, with a recent (4 months ago) mitral valve replacement (St Jude 29) and maze procedure, was referred to the… 
2002
2002
Pulmonary hemorrhage after percutaneous coronary intervention with abciximab therapy.
Abciximab has a key role in the treatment of patients with acute coronary syndromes undergoing percutaneous coronary intervention… 
2000
2000
High Platelet Count in Platelet-Rich Plasma Reduces Measured Platelet Inhibition by Abciximab but not Tirofiban nor Eptifibatide Glycoprotein IIb/IIIa Receptor Antagonists
We evaluated the differential effect of platelet count in platelet-rich plasma (PRP) on the level of ex vivo inhibition of… 
2000
2000
Abciximab in Ischemic Stroke Investigators Abciximab in Acute Ischemic Stroke
  • 2000
  • Corpus ID: 36758924
Background and Purpose —Abciximab is a potent parenterally administered platelet glycoprotein IIb/IIIa antagonist. Because this… 
1998
1998
Femoral Arterial Hemostasis using the Angio-Sealª System after Coronary and Vascular Percutaneous Angioplasty and Stenting.
The procedures of left cardiac catheterization and revascularization by angioplasty are associated with a substantial risk of… 
1996
1996
Platelet Glycoprotein IIb/IIIa Receptor Inhibitors in Coronary Artery Disease
Drugs that dissolve blood clots (thrombolytic agents) and drugs that prevent clot propagation (antiplatelet agents and… 
Review
1996
Review
1996
Risk stratification in patients with unstable angina: 'déjà vu all over again'?
Considerable progress has occurred in our understanding of the pathophysiology and therapy of unstable angina pectoris.1 2 3… 
1994
1994
Contribution of platelets and the vessel wall to the antithrombotic effects of a single bolus injection of Fab fragments of the antiplatelet GPIIb/IIIa antibody 7E3 in a canine arterial eversion…
The contribution of platelets and the vessel wall to the antithrombotic effects of a single intravenous bolus injection of 0.8 mg… 
1994
1994
Fibrinogen receptor antagonists
Fibrinogen receptor antagonists represent a potential new form of antithrombotic therapy for the treatment or prevention of… 
1992
1992
Platelet morphologic changes and fibrinogen receptor localization. Initial responses in ADP-activated human platelets.
Platelet exposure to agonists results in rapid morphologic changes paralleled by fibrinogen binding and platelet aggregation. The…